Cite

HARVARD Citation

    Johnson, C. et al. (n.d.). Combinatorial therapy with an IL-15 superagonist (ALT-803) and anti-PD-L1 mAb augment T cell mediated anti-tumor immunity in mice. Journal for immunotherapy of cancer. p. . [Online]. 
  
Back to record